Skip to main content
Clinical Trials/NCT04811768
NCT04811768
Completed
Phase 4

Comparative Clinical and Histological Investigation of Graft Integration Following Piezosurgically Retrieved Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation - Prospective Randomized Controlled Study

Semmelweis University1 site in 1 country40 target enrollmentMarch 1, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Maxillary Sinus Augmentation
Sponsor
Semmelweis University
Enrollment
40
Locations
1
Primary Endpoint
Duration of surgery
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of the present prospective randomized controlled study is to clinically and histologically investigate the safety and efficacy of bony wall repositioning compared to rotary window preparation with membrane coverage in maxillary sinus floor augmentation.

Detailed Description

40 patients were randomly divided in two study groups after radiological and clinical evaluation. Both groups received bone grafting by a xenogeneic bone substitute (BSM, cerabone, botiss biomaterials GmbH, Zossen, Germany) using the lateral approach. In the bony wall group (BW), following piezosurgery the retrieved bony wall was repositioned. In the collagen membrane group (CM), the lateral window was created by rotary instruments, covered via a native collagen membrane (collprotect, botiss biomaterials GmbH, Zossen, Germany). After 6 months, biopsies were taken to analyze both approaches in terms of new bone formation. Duration of treatment, the number of perforations, postoperative patient discomfort were registered. Established histopathological analysis and histomorphometrical measurements to analyze the tissue reactions and the tissue distribution, i.e., the fractions of newly formed bone tissue (NB), of remaining bone substitute material (BSM) and connective tissue (CT), were conducted.

Registry
clinicaltrials.gov
Start Date
March 1, 2017
End Date
May 30, 2018
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Balint Molnar

Dr. Balint Molnar DMD, PhD, associate professor

Semmelweis University

Eligibility Criteria

Inclusion Criteria

  • at least one missing maxillary premolar or molar
  • at least 7 mm crestal bone width confirmed by preoperative ConeBeam Tomography (CBCT)
  • maximally 5 mm residual bone height at the sinus floor confirmed by preoperative ConeBeam Tomography (CBCT)
  • full mouth plaque and bleeding scores (FMPS and FMBS) \<20%
  • satisfactory patient compliance (e.g. to participate in follow-up procedures)
  • signed informed consent.

Exclusion Criteria

  • clinically relevant diseases (e.g.: diabetes, rheumatism cancer)
  • untreated periodontitis
  • systemic steroid use
  • bisphosphonate use
  • acute or chronic inflammatory processes
  • previous endoscopic sinus surgery
  • previous sinus floor elevation
  • GBR-treatment at the study site
  • GTR-treatment at the study site
  • tooth removal within 6 weeks prior to surgery

Outcomes

Primary Outcomes

Duration of surgery

Time Frame: During smaxillary sinus augmentation

Recorded in minutes

Secondary Outcomes

  • Duration of lateral window preparation(During maxillary sinus augmentation)
  • Duration of mucosa preparation(During maxillary sinus augmentation)
  • Visual Analog Scale (Minimum value 0, Maximum value 100, the higher the worse)(1 day postoperatively)
  • Postoperative Edema Score(3 days postoperatively)
  • Histomorphometrical analysis(Following reentry 6 months after maxillary sinus augmentation)

Study Sites (1)

Loading locations...

Similar Trials